Yolanda C. Nesbeth, Ph.D.

Affiliations: 
2010 Immunology and Microbiology Dartmouth College, Hanover, NH, United States 
Area:
Immunology
Google:
"Yolanda Nesbeth"

Parents

Sign in to add mentor
Jose R. Conejo-Garcia grad student 2010 Dartmouth
 (Endogenous antitumor immunity elicited by adoptively transferred lymphocytes through CCL5 and CD40L signaling, and dendritic cell depletion.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hinchcliff M, Toledo DM, Taroni JN, et al. (2018) Mycophenolate mofetil treatment of systemic sclerosis reduces myeloid cell numbers and attenuates the inflammatory gene signature in skin. The Journal of Investigative Dermatology
Cubillos-Ruiz JR, Martinez D, Scarlett UK, et al. (2010) CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells. Oncotarget. 1: 329-38
Nesbeth Y, Conejo-Garcia JR. (2010) Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity. Clinical & Developmental Immunology. 2010: 139304
Nesbeth YC, Martinez DG, Toraya S, et al. (2010) CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 5654-62
Scarlett UK, Cubillos-Ruiz JR, Nesbeth YC, et al. (2009) In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells. Cancer Research. 69: 7329-37
Cubillos-Ruiz JR, Engle X, Scarlett UK, et al. (2009) Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. The Journal of Clinical Investigation. 119: 2231-44
Nesbeth Y, Scarlett U, Cubillos-Ruiz J, et al. (2009) CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion. Cancer Research. 69: 6331-8
Huarte E, Cubillos-Ruiz JR, Nesbeth YC, et al. (2008) Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer Research. 68: 7684-91
Huarte E, Cubillos-Ruiz JR, Nesbeth YC, et al. (2008) PILAR is a novel modulator of human T-cell expansion. Blood. 112: 1259-68
See more...